PMC:7795856 / 22161-22501
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 385 | 29-34 | Gene | denotes | GLP-1 | Gene:2641 |
| 386 | 39-42 | Gene | denotes | GIP | Gene:2695 |
| 387 | 51-54 | Gene | denotes | Tα1 | Gene:134864 |
| 388 | 59-65 | Gene | denotes | GM-CSF | Gene:1437 |
| 393 | 196-222 | Chemical | denotes | arginylglycylaspartic acid | MESH:C047981 |
| 398 | 302-307 | Disease | denotes | tumor | MESH:D009369 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T21 | 302-307 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T126 | 72-337 | Sentence | denotes | Alternatively, the biologically active protein/peptide can be linked via the PAS sequence to a targeting domain such as the arginylglycylaspartic acid peptide RGD peptide which binds to integrins αVβ3 and αVβ5 in order to enhance tumor penetration and accumulation. |